Oral Abstract Session: Parallel Session 13: Next-generation strategies in cell and gene therapy 2
Friday October 24, 2025 from 11:30 to 12:30
Hall A2-3
Moderator
Lectures
-
11:30 - 11:42PS13.1 Advancing CD8+ Treg cell therapy to the clinic for the treatment of kidney transplanted patientsDr. Carole Guillonneau, France
-
11:42 - 11:54PS13.2 Clinical implementation of advanced biotechnologies for liver failure management in Belarus: stem cell therapies and tissue engineering approachesDr. Denis Efimov, Belarus
-
11:54 - 12:06PS13.3 Exploratory physician-initiated clinical trial for innovative angiogenic therapy using injectable cell scaffold (ICS-001) with peripheral blood mononuclear cells for chronic limb threatening ischemiaProf. Kenichi Yamahara, Japan
-
12:06 - 12:18PS13.4 Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trialDr. Masayuki Kuroda, Japan
-
12:18 - 12:30PS13.5 First‑in‑human trial of the treatment with human embryonic stem (ES) cell-derived hepatocyte-like cells for infantile urea cycle disordersDr. Shin Enosawa, Japan